Literature DB >> 24339057

Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.

Jumpei Teramachi1, Hua Zhou, Mark A Subler, Yukiko Kitagawa, Deborah L Galson, David W Dempster, Jolene J Windle, Noriyoshi Kurihara, G David Roodman.   

Abstract

Measles virus nucleocapsid protein (MVNP) expression in osteoclasts (OCLs) and mutation of the SQSTM1 (p62) gene contribute to the increased OCL activity in Paget's disease (PD). OCLs expressing MVNP display many of the features of PD OCLs. Interleukin-6 (IL-6) production is essential for the pagetic phenotype, because transgenic mice with MVNP targeted to OCLs develop pagetic OCLs and lesions, but this phenotype is absent when MVNP mice are bred to IL-6(-/-) mice. In contrast, mutant p62 expression in OCL precursors promotes receptor activator of NF-κB ligand (RANKL) hyperresponsivity and increased OCL production, but OCLs that form have normal morphology, are not hyperresponsive to 1,25-dihydroxyvitamin D3 (1,25-(OH)2 D3 ), nor produce elevated levels of IL-6. We previously generated p62(P394L) knock-in mice (p62KI) and found that although OCL numbers were increased, the mice did not develop pagetic lesions. However, mice expressing both MVNP and p62KI developed more exuberant pagetic lesions than mice expressing MVNP alone. To examine the role of elevated IL-6 in PD and determine if MVNP mediates its effects primarily through elevation of IL-6, we generated transgenic mice that overexpress IL-6 driven by the tartrate-resistant acid phosphatase (TRAP) promoter (TIL-6 mice) and produce IL-6 at levels comparable to MVNP mice. These were crossed with p62KI mice to determine whether IL-6 overexpression cooperates with mutant p62 to produce pagetic lesions. OCL precursors from p62KI/TIL-6 mice formed greater numbers of OCLs than either p62KI or TIL-6 OCL precursors in response to 1,25-(OH)2 D3 . Histomorphometric analysis of bones from p62KI/TIL-6 mice revealed increased OCL numbers per bone surface area compared to wild-type (WT) mice. However, micro-quantitative CT (µQCT) analysis did not reveal significant differences between p62KI/TIL-6 and WT mice, and no pagetic OCLs or lesions were detected in vivo. Thus, increased IL-6 expression in OCLs from p62KI mice contributes to increased responsivity to 1,25-(OH)2 D3 and increased OCL numbers, but is not sufficient to induce Paget's-like OCLs or bone lesions in vivo.
© 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  IL-6; MVNP; OSTEOCLASTS; P62; PAGET'S DISEASE OF BONE

Mesh:

Substances:

Year:  2014        PMID: 24339057      PMCID: PMC4361000          DOI: 10.1002/jbmr.2158

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  26 in total

1.  A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.

Authors:  Anna Daroszewska; Robert J van 't Hof; Javier A Rojas; Robert Layfield; Euphemie Landao-Basonga; Lorraine Rose; Ken Rose; Stuart H Ralston
Journal:  Hum Mol Genet       Date:  2011-04-21       Impact factor: 6.150

2.  Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

Authors:  G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

Review 5.  Metabolic consequences of bone turnover in Paget's disease of bone.

Authors:  S M Krane; L S Simon
Journal:  Clin Orthop Relat Res       Date:  1987-04       Impact factor: 4.176

Review 6.  Paget's disease of bone.

Authors:  D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

7.  Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.

Authors:  Kumaran Sundaram; Srinivasan Shanmugarajan; D Sudhaker Rao; Sakamuri V Reddy
Journal:  Endocrinology       Date:  2011-08-30       Impact factor: 4.736

8.  Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease.

Authors:  Noriyoshi Kurihara; Sakamuri V Reddy; Norie Araki; Seiichi Ishizuka; Keiichi Ozono; Jillian Cornish; Tim Cundy; Frederick R Singer; G David Roodman
Journal:  J Bone Miner Res       Date:  2004-03-15       Impact factor: 6.741

9.  The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.

Authors:  Erming Tian; Fenghuang Zhan; Ronald Walker; Erik Rasmussen; Yupo Ma; Bart Barlogie; John D Shaughnessy
Journal:  N Engl J Med       Date:  2003-12-25       Impact factor: 91.245

10.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.

Authors:  H Sudo; H A Kodama; Y Amagai; S Yamamoto; S Kasai
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

View more
  10 in total

1.  Osteoclast derivation from mouse bone marrow.

Authors:  Ruth Tevlin; Adrian McArdle; Charles K F Chan; John Pluvinage; Graham G Walmsley; Taylor Wearda; Owen Marecic; Michael S Hu; Kevin J Paik; Kshemendra Senarath-Yapa; David A Atashroo; Elizabeth R Zielins; Derrick C Wan; Irving L Weissman; Michael T Longaker
Journal:  J Vis Exp       Date:  2014-11-06       Impact factor: 1.355

2.  NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone.

Authors:  Yuvaraj Sambandam; Kumaran Sundaram; Takamitsu Saigusa; Sundaravadivel Balasubramanian; Sakamuri V Reddy
Journal:  Bone       Date:  2017-05-12       Impact factor: 4.398

3.  Measles virus nucleocapsid protein increases osteoblast differentiation in Paget's disease.

Authors:  Jumpei Teramachi; Yuki Nagata; Khalid Mohammad; Yuji Inagaki; Yasuhisa Ohata; Theresa Guise; Laëtitia Michou; Jacques P Brown; Jolene J Windle; Noriyoshi Kurihara; G David Roodman
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

Review 4.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

Review 5.  Pathobiology of Paget's Disease of Bone.

Authors:  Deborah L Galson; G David Roodman
Journal:  J Bone Metab       Date:  2014-05-31

Review 6.  Epidemiology and pathology of Paget's disease of bone - a review.

Authors:  Elena Nebot Valenzuela; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2016-09-06

7.  Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice.

Authors:  Lena Marie Westermann; Anke Baranowsky; Giorgia Di Lorenzo; Tatyana Danyukova; Jamie Soul; Jean-Marc Schwartz; Gretl Hendrickx; Michael Amling; Stefan Rose-John; Christoph Garbers; Thorsten Schinke; Sandra Pohl
Journal:  Sci Rep       Date:  2021-02-11       Impact factor: 4.379

8.  Inhibition of NFAM1 suppresses phospho-SAPK/JNK signaling during osteoclast differentiation and bone resorption.

Authors:  Purushoth Ethiraj; Ishraq A Haque; Anna K Alford; Wenyu Gou; Toolika Singh; Yuvaraj Sambandam; Jessica D Hathaway-Schrader; Sakamuri V Reddy
Journal:  J Cell Biochem       Date:  2021-07-06       Impact factor: 4.480

9.  Detection of SQSTM1/P392L post-zygotic mutations in Paget's disease of bone.

Authors:  Sabrina Guay-Bélanger; Sylvain Picard; Edith Gagnon; Jean Morissette; Ethel S Siris; Philippe Orcel; Jacques P Brown; Laëtitia Michou
Journal:  Hum Genet       Date:  2014-09-21       Impact factor: 4.132

10.  Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.

Authors:  Yuki Nagata; Kazuaki Miyagawa; Yasuhisa Ohata; Daniela N Petrusca; Gabriel M Pagnotti; Khalid S Mohammad; Theresa A Guise; Jolene J Windle; G David Roodman; Noriyoshi Kurihara
Journal:  J Cell Biochem       Date:  2020-10-27       Impact factor: 4.429

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.